₹18.20
NSE close, 16 Nov 2026
−63.85%
MEDISTEP HEALTHCARE is a small cap company, listed on NSE SME under the symbol MEDISTEP. At ₹18.20 a share, the market values the whole company at ₹26 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹71 crore and a net profit of ₹6 crore, an operating margin of 11.6%.
The market values the company at 4.2 times its profit over the last twelve months and 0.63 times its book value; its return on equity is 14.9% and its borrowings are 0.13 times its equity.
Promoters hold 68.96% of the shares. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 18.8%, and it is 39.3% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | 6M to Sep 2025 S | 6M to Mar 2026 S | 6M to Sep 2026 |
|---|---|---|---|
| Sales | 35.1 | 35.8 | 37.4 |
| Expenses | 31.1 | 31.5 | 33.0 |
| Operating profit | 4.0 | 4.3 | 4.4 |
| Operating margin | 11.4% | 11.9% | 11.8% |
| Other income | 0 |
The financial results for the period ended September 30, 2026.
The financial results for the period ended September 30, 2026.
Has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter ended September, 2026
A copy Srutinizers report of Annual General Meeting held on September 17, 2026. Further, the company has informed the Exchange regarding voting results.
| 0 |
| Interest | 0 | 0.3 | 0.2 |
|---|
| Depreciation | 0.0 | 0.0 | 0.0 |
|---|
| Profit before tax | 4.0 | 4.0 | 4.2 |
|---|
| Tax | 1.0 | 1.0 | 1.1 |
|---|
| Net profit | 3.0 | 3.0 | 3.1 |
|---|
| EPS (₹) | 2.61 | 2.12 | 2.18 |
|---|
₹ crore, financial years to March.
| Line | FY26 S |
|---|---|
| Sales | 70.8 |
| Expenses | 62.6 |
| Operating profit | 8.3 |
| Operating margin | 11.6% |
| Other income | 0.0 |
| Interest | 0.3 |
| Depreciation | 0.0 |
| Profit before tax | 8.0 |
| Tax | 2.0 |
| Net profit | 6.0 |
| EPS (₹) | 4.68 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | −19.5 | 0.9 |
| From investing | −0.0 | −0.5 |
| From financing | 18.8 | −0.3 |
| Spent on fixed assets | −0.0 | −0.5 |
| Free cash flow | −19.5 | 0.4 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 8.4% |
| Operating margin | 11.6% |
| Return on equity | 15.8% |
| Return on capital employed | 19.2% |
| Return on assets | 11.9% |
| Debt to equity | 0.14 |
| Interest coverage | 33.00 |
| Debt to assets | 0.10 |
| Current ratio | 4.03 |
| Quick ratio | 3.53 |
| Cash ratio | 0.05 |
| Asset turnover | 1.41 |
| Fixed asset turnover | 590.25 |
| Inventory turnover | 10.00 |
| Receivables turnover | 1.80 |
| Gross margin | 12.7% |
| Cash from operations to profit | -326.0% |
| Effective tax rate | 25.1% |
Proceedings of Annual General Meeting held on September 17, 2026
Intimation of book closure for financial year 2025-2026
Outcome of Board Meeting held on August 24, 2026.
Notice of undefined to be held on September 17, 2026